Delivery Order SPE2DB22D3004-SPE2DB25FRV37
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,881.75 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Viberzi 100 mg tablets (60-count packages) with a ceiling value of $3,030.63. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The order is scheduled for completion by June 6, 2025, and will...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $1,093.82 and an ultimate completion date of September 29, 2025. This is a non-set-aside competitive award representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,716.59. The award, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a firm fixed price of $1,149.76, with an ultimate completion date of June 3, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a ceiling value of $3,587.92 under a firm fixed price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively determined with no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viberzi 100 mg tablets (60-count) with a ceiling value of $1,718.59. This is a firm fixed-price delivery order issued under a competitively awarded, non-set-aside procurement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,532.21 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on June 27, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle extending through December 2026. The product will be performed at AmerisourceBergen's...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRV37Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The award represents a competitive delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is a child contract issued under AmerisourceBergen's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a wide range of medications and medical supplies to support military healthcare programs and other federal medical procurement needs. Viberzi (eluxadoline), used to treat irritable bowel syndrome with diarrhea, exemplifies the specialized therapeutic medications the company distributes through its federal contracts supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/5/25 |